Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Residents in eastern Congo cling to hope as a new Ebola treatment trial begins

Researchers will test remdesivir and MBP134 in up to 1,000 patients as the outbreak grows and no licensed Ebola treatment exists.

  • On Thursday, researchers launched a clinical trial at the Evangelical Medical Center in Bunia, DRC, evaluating whether the experimental antibody treatment MBP134 improves survival among patients infected with Bundibugyo Ebola.
  • Unlike the Zaire strain, for which vaccines exist, no licensed treatment is currently available for the Bundibugyo Ebola species, which has already caused more than 1,400 diagnoses and 438 deaths.
  • Community mistrust, overcrowded facilities, and insecurity hinder the outbreak response, with incident manager Pierre Akilimali noting that nearly 3 out of 4 Ebola deaths occur outside health centers.
  • Survivor Gladys Munguro, discharged two weeks ago, called the experimental phase "necessary" to improve survival chances, while Bunia resident Audrey Tengetenge said the trials represent a "light at the end of the tunnel."
  • Professor Placide Mbala, coordinator of laboratory activities, stated the research could continue for between three and six months, with a second phase eventually including healthcare workers and high-risk individuals.
Insights by Ground AI

68 Articles

Lean Left

More than 500 people have died from Ebola in Congo, WHO has started experimental treatmentIn DR Congo, a clinical trial of the experimental treatment of the Ebola strain Bundibujyo has started. The outbreak has already claimed more lives 500 people and covered almost 1600 people.

·Kyiv, Ukraine
Read Full Article
The Japan TimesThe Japan Times
+2 Reposted by 2 other sources
Center

Experimental Ebola trial begins in Congo as death toll tops 500

The World Health Organization-sponsored trial will test the monoclonal antibody cocktail MBP134 and the antiviral remdesivir alongside optimized supportive care.

·Japan
Read Full Article
WLKYWLKY
+26 Reposted by 26 other sources
Center

Residents in Congo cling to hope as a new Ebola treatment trial begins

Residents at the epicenter of Congo’s Ebola outbreak are pinning their hopes on two experimental treatments.

·Louisville, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 59% of the sources are Center
59% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

France24 broke the news in France on Friday, July 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal